Evidence map›Paper›PMID 22879633›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2012

Racial/ethnic differences in sex hormone levels among postmenopausal women in the diabetes prevention program.

Catherine Kim, Sherita Hill Golden, Kieren J Mather, Gail A Laughlin, Shengchun Kong, Bin Nan, Elizabeth Barrett-Connor, John F Randolph, Diabetes Prevention Program Research Group

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Sarcopenia in Menopausal Women: Current Perspectives.International journal of women's health · 2022
    Review
  16. Review
  17. Aging, Cardiovascular Risk, and SHBG Levels in Men and Women From the General Population.The Journal of clinical endocrinology and metabolism · 2021
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Catherine KimDepartments of Biostatistics and Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan 48109-5429, USA. cathkim@umich.edu
Sherita Hill Golden
Kieren J Mather
Gail A Laughlin
Shengchun Kong
Bin Nan
Elizabeth Barrett-Connor
John F Randolph
Diabetes Prevention Program Research Group
University of Michigan–Ann Arbor · USUniversity of California, San Diego · USIndiana University – Purdue University Indianapolis · USJohns Hopkins University · USMichigan Medicine · US

Funding

PRIMARY PREVENTION TRIAL--DATA COORDINATING CENTERU01DK048489 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI JABLONSKI, KATHLEEN ANN, TEMPROSA, MARINELLA · 1994 to 2021
$84.8M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI AHIMA, REXFORD S. · 2013 to 2017
$9.7M
Primary and Tertiary Prevention of type 2 diabetesZIADK075078 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANSON, ROBERT · 2012 to 2025
$4.6M
Sex Hormones in Postmenopausal Women in the Diabetes Prevention ProgramR01DK083297 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CATHERINE · 2010 to 2012
$1.1M
Type 2 Diabetes Risk in Women With Gestational DiabetesK23DK071552 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CATHERINE · 2006 to 2010
$674k
NIDDK NIH HHS K23 DK071552NIDDK NIH HHS K23DK071552NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK079637NIDDK NIH HHS P30 DK092926NIDDK NIH HHS R01 DK083297NIDDK NIH HHS R01DK083297NIDDK NIH HHS U01 DK048489NIDDK NIH HHS U01DK048489
6 · The paper itself

Abstract

contextSex hormones may differ by race/ethnicity in postmenopausal women. Whether racial/ethnic differences also exist among those who are overweight and glucose intolerant is not clear.

objectivesThe objective of the study was to compare sex hormones by race/ethnicity [non-Hispanic white (NHW), Hispanic, African-American (AA)] in overweight, glucose-intolerant, postmenopausal women.

designThis was a secondary analysis of a randomized controlled trial.

participantsParticipants included postmenopausal glucose-intolerant women participating in the Diabetes Prevention Program.

interventionsInterventions included intensive lifestyle modification (consisting of diet and physical activity) or metformin 850 mg twice a day vs. placebo.

main outcome measuresBaseline levels and 1-yr intervention-related changes in SHBG, total and bioavailable estradiol (E2), total and bioavailable testosterone, and dehydroepiandrosterone were measured.

resultsAt baseline, among women not using estrogen (n = 370), NHW had higher total and bioavailable E2 and testosterone levels than Hispanics independent of age, type of menopause, waist circumference, alcohol intake, and current smoking. NHW also had higher levels of bioavailable E2 and lower levels of SHBG than AA. At baseline, among estrogen users (n = 310), NHW had higher total and bioavailable E2 than Hispanics and higher levels of SHBG than AA after adjustment. At 1 yr, among women not using estrogen, NHW had larger declines in total E2 and bioavailable E2 levels than AA after adjustment for the above covariates, changes in waist circumference, and randomization arm. At 1 yr, among estrogen users, sex hormone changes did not differ by race/ethnicity.

conclusionsAmong postmenopausal women, there were significant race/ethnicity differences in baseline sex hormones and changes in sex hormones.

Indexed as

AgedBlood GlucoseBody Mass IndexDehydroepiandrosteroneEstradiolEthnicityFemaleGlucose IntoleranceHumansHypoglycemic AgentsLife StyleMetforminMiddle AgedPostmenopauseSex Hormone-Binding GlobulinTestosteroneBlood GlucoseDehydroepiandrosteroneEstradiolHypoglycemic AgentsMetforminSex Hormone-Binding GlobulinTestosterone

Identifiers

PMID22879633
PMCPMC3485611
OpenAlexW2129223608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.